D.A. Davidson & Co’s bluebird bio BLUE Stock Holding History

D.A. Davidson & Co’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-108	Closed	-$220K	–	1016
2019 Q1	$220K	Buy	+108	New	+$190K	﹤0.01%	1010
2018 Q3	–	Sell	-100	Closed	-$202K	–	1164
2018 Q2	$202K	Buy	100 +4	+4%	+$9.12K	﹤0.01%	1032
2018 Q1	$212K	Buy	96 +3	+3%	+$7.63K	﹤0.01%	981
2017 Q4	$214K	Buy	+93	New	+$189K	﹤0.01%	985
2017 Q3	–	Sell	-81	Closed	-$110K	–	1181
2017 Q2	$110K	Hold	81	–	–	﹤0.01%	1223
2017 Q1	$95K	Sell	81 -8	-9%	-$8.16K	﹤0.01%	1268
2016 Q4	$70K	Buy	89 +20	+29%	+$15.9K	﹤0.01%	1458
2016 Q3	$61K	Hold	69	–	–	﹤0.01%	1429
2016 Q2	$38K	Hold	69	–	–	﹤0.01%	1512
2016 Q1	$38K	Buy	69 +15	+28%	+$9.21K	﹤0.01%	1490
2015 Q4	$44K	Buy	54 +39	+260%	+$39K	﹤0.01%	1446
2015 Q3	$17K	Buy	+15	New	+$27.4K	﹤0.01%	1708

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's BLUE Position: Q2 2019 in Review

D.A. Davidson & Co sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 108 shares — an estimated $220K sold.

D.A. Davidson & Co first reported a position in BLUE in Q3 2015 and held it in 12 quarters. The position peaked at $220K in Q1 2019. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

D.A. Davidson & Co reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
D.A. Davidson & Co sold 108 bluebird bio shares in Q2 2019, an estimated $220K.
D.A. Davidson & Co first reported a position in bluebird bio in Q3 2015 and held it in 12 quarters.
D.A. Davidson & Co's bluebird bio position peaked at $220K in Q1 2019.
273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.